Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014, Article ID 704371, 7 pages
http://dx.doi.org/10.1155/2014/704371
Case Report

36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature

Department of Hematology and Oncology, Jacobi Medical Center Affiliate of Albert Einstein College of Medicine, 1400 Pelham Parkway, Bronx, NY 10461, USA

Received 16 July 2014; Accepted 8 September 2014; Published 15 October 2014

Academic Editor: Akimichi Ohsaka

Copyright © 2014 Marianna Strakhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Thomas L. Ortel, Doruk Erkan, and Craig S. Kitchens, “How I treat catastrophic thrombotic syndromes,” Blood, vol. 126, no. 11, pp. 1285–1293, 2015. View at Publisher · View at Google Scholar
  • Cornelia Speth, Günter Rambach, Reinhard Würzner, Cornelia Lass-Flörl, Huda Kozarcanin, Osama A. Hamad, Bo Nilsson, and Kristina N. Ekdahl, “Complement and platelets: Mutual interference in the immune network,” Molecular Immunology, 2015. View at Publisher · View at Google Scholar
  • Hyunkyung Park, Jeonghwan Youk, Seongcheol Cho, Ji Hyun Lee, Yeonjoo Choi, and Youngil Koh, “Outcome of Disseminated Intravascular Coagulation without Documented Antiphospholipid Antibody Successfully Treated with Rituximab,” Soonchunhyang Medical Science, vol. 21, no. 2, pp. 154–158, 2015. View at Publisher · View at Google Scholar
  • Doruk Erkan, and Jane E Salmon, “The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.,” Turkish journal of haematology : official journal of Turkish Society of Haematology, vol. 33, no. 1, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Maria Gerosa, Pier Luigi Meroni, and Doruk Erkan, “Recognition and management of antiphospholipid syndrome,” Current Opinion in Rheumatology, vol. 28, no. 1, pp. 51–59, 2016. View at Publisher · View at Google Scholar
  • Pier Luigi Meroni, Paolo Macor, Paolo Durigutto, Luca De Maso, Maria Gerosa, Mariano Ferraresso, Maria Orietta Borghi, Tom Eirik Mollnes, and Francesco Tedesco, “Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery,” Blood, vol. 127, no. 3, pp. 365–367, 2016. View at Publisher · View at Google Scholar
  • M. Cataldi, and A. Cavaccini, “Eculizumab☆,” Reference Module in Biomedical Sciences, 2016. View at Publisher · View at Google Scholar
  • Maria Izabel de Holanda, Luis Cristóvão Pôrto, Teresa Wagner, Luis Fernando Christiani, and Lilian M. P. Palma, “Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review,” Clinical Rheumatology, 2017. View at Publisher · View at Google Scholar
  • Leendert A. Trouw, Matthew C. Pickering, and Anna M. Blom, “The complement system as a potential therapeutic target in rheumatic disease,” Nature Reviews Rheumatology, 2017. View at Publisher · View at Google Scholar
  • Teresa Cavero, Miquel Blasco, Ana Jarque, Alba García, Santiago Mendizabal, Eva Gavela, Manuel Macía, Luis F Quintana, Ana María Romera, Josefa Borrego, Emi Arjona, Cristina Rabasco, Mario Espinosa, José Portolés, Carolina Gracia-Iguacel, Emilio González-Parra, Pedro Aljama, Enrique Morales, Mercedes Cao, Santiago Rodríguez de Córdoba, Manuel Praga, Antía López, Elena Román, Ana Ávila, Ángel Sevillano, Ana Huerta, Jorge Rojas-Rivera, and Carolina Fuentes, “Eculizumab in secondary atypical haemolytic uraemic syndrome.,” Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 32, no. 3, pp. 466–474, 2017. View at Publisher · View at Google Scholar
  • Laurie S. Davis, and Andreas M. Reimold, “Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus,” Rheumatology, vol. 56, no. suppl_1, pp. i100–i113, 2017. View at Publisher · View at Google Scholar
  • Vicky Brocklebank, and David Kavanagh, “Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.,” Clinical kidney journal, vol. 10, no. 5, pp. 600–624, 2017. View at Publisher · View at Google Scholar
  • Mathilde Guillot, Cedric Rafat, David Buob, Paul Coppo, Matthieu Jamme, Eric Rondeau, Olivier Fain, and Arsène Mekinian, “Eculizumab for catastrophic antiphospholipid syndrome—a case report and literature review,” Rheumatology, 2018. View at Publisher · View at Google Scholar